Overexpression of microRNA-620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD

Patients with triple negative breast cancer (TNBC) have a poor survival rate following chemotherapy due to drug resistance. Notably, the molecular mechanism of drug resistance remains elusive. Between December 2011 and December 2014, 36 TNBC samples were obtained from Liaocheng People's Hospita...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chao, Zhao, Aili, Tan, Tingzhao, Wang, Yuan, Shen, Zhentao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566059/
https://www.ncbi.nlm.nih.gov/pubmed/31258693
http://dx.doi.org/10.3892/etm.2019.7601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566059/
https://www.ncbi.nlm.nih.gov/pubmed/31258693
http://dx.doi.org/10.3892/etm.2019.7601

Ejemplares similares